Hostname: page-component-6766d58669-tq7bh Total loading time: 0 Render date: 2026-05-23T15:26:21.554Z Has data issue: false hasContentIssue false

Immediate and long-term efficacy of persistent throat symptoms to gastric inlet patch ablation

Published online by Cambridge University Press:  24 July 2025

Chang Woo Lee*
Affiliation:
Department of Otolaryngology-Head and Neck Surgery, University Hospitals Dorset NHS Foundation Trust, Poole, UK
Tabi Unsworth-White
Affiliation:
Department of Otolaryngology-Head and Neck Surgery, University Hospitals Dorset NHS Foundation Trust, Poole, UK
Roanna Norman
Affiliation:
Department of Otolaryngology-Head and Neck Surgery, University Hospitals Dorset NHS Foundation Trust, Poole, UK
Sebastian Matthew Joseph Powell
Affiliation:
Department of Otolaryngology-Head and Neck Surgery, University Hospitals Dorset NHS Foundation Trust, Poole, UK
Natalija Snovak
Affiliation:
Department of Otolaryngology-Head and Neck Surgery, University Hospitals Dorset NHS Foundation Trust, Poole, UK
Kate J Heathcote
Affiliation:
Department of Otolaryngology-Head and Neck Surgery, University Hospitals Dorset NHS Foundation Trust, Poole, UK
Lachlan Ayres
Affiliation:
Department of Gastroenterology, University Hospitals Dorset NHS Foundation Trust, Poole, UK
*
Corresponding author: Chang Woo Lee; Email: changwoo.lee@nhs.net

Abstract

Objective

Efficacy of gastric inlet patch (GIP) ablation using argon plasma coagulation (APC) for patients presenting with persistent throat symptoms was evaluated.

Methods

Retrospective observational study from a single university hospital. Consecutive patients who had GIP ablation for persistent throat symptoms between 01/10/2018-31/10/2023 were reviewed and patients who met all of the set inclusion and exclusion criteria were included in this study for analysis.

Results

50% (n = 18/36) of patients responded to APC ablation (median follow-up 3 months) with their post-ablation GETS score decreasing by 30-100%. Long-term follow-up results could be obtained from 22 patients (n = 22/36) and 75% (n = 9/12) had their clinical effects maintained (median follow-up 4.5 years; range 2.7–5.8 years).

Conclusion

GIP ablation can be a very effective treatment for patients with persistent throat symptoms with its therapeutic effects long-lasting. Future studies should focus on evaluating the optimal patient selection process for GIP ablation for persistent throat symptoms.

Information

Type
Main Article
Copyright
© The Author(s), 2025. Published by Cambridge University Press on behalf of J.L.O. (1984) LIMITED.

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable